Browse CBX1 in pancancer

Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Domain, Function and Classification
> Gene Ontology
> KEGG and Reactome Pathway
> Domain, Function and Classification
 
Domain PF00385 Chromo (CHRromatin Organisation MOdifier) domain
PF01393 Chromo shadow domain
Function

Component of heterochromatin. Recognizes and binds histone H3 tails methylated at 'Lys-9', leading to epigenetic repression. Interaction with lamin B receptor (LBR) can contribute to the association of the heterochromatin with the inner nuclear membrane.

Classification
Class Modification Substrate Product PubMed
Histone modification read # H3K9me3, H3K27me3 # 21047797
> Gene Ontology
 
Biological Process -
Molecular Function GO:0003682 chromatin binding
GO:1990226 histone methyltransferase binding
Cellular Component GO:0000775 chromosome, centromeric region
GO:0000781 chromosome, telomeric region
GO:0000784 nuclear chromosome, telomeric region
GO:0000785 chromatin
GO:0000790 nuclear chromatin
GO:0000792 heterochromatin
GO:0001939 female pronucleus
GO:0001940 male pronucleus
GO:0005720 nuclear heterochromatin
GO:0005721 pericentric heterochromatin
GO:0005819 spindle
GO:0010369 chromocenter
GO:0044454 nuclear chromosome part
GO:0045120 pronucleus
GO:0098687 chromosomal region
> KEGG and Reactome Pathway
 
KEGG -
Reactome -
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Mutation landscape in primary tumor tissue from TCGA
> Mutation landscape in cancer cell line from CCLE
> All mutations from COSMIC database V81
> Variations from text mining
> The Cancer Genome Atlas (TCGA)
 
> Cancer Cell Line Encyclopedia (CCLE)
 
There is no record.
> Catalogue of Somatic Mutations in Cancer (COSMIC)
 
COSMIC ID CDS change AA change Mutation Type Anatomical Site
COSM239169c.362G>Ap.R121QSubstitution - MissenseProstate
COSM5419125c.482T>Cp.I161TSubstitution - MissenseHaematopoietic_and_lymphoid_tissue
COSM1710408c.451G>Ap.E151KSubstitution - MissenseSkin
COSM301883c.525G>Ap.S175SSubstitution - coding silentUpper_aerodigestive_tract
COSM1563790c.555C>Ap.N185KSubstitution - MissenseLarge_intestine
COSM472947c.422C>Tp.S141FSubstitution - MissenseKidney
COSM3795724c.371G>Cp.G124ASubstitution - MissenseUrinary_tract
COSM2697272c.354G>Ap.E118ESubstitution - coding silentLarge_intestine
COSM1479689c.483A>Tp.I161ISubstitution - coding silentBreast
COSM1236233c.309G>Tp.K103NSubstitution - MissenseCervix
COSM4067326c.149A>Gp.N50SSubstitution - MissenseStomach
COSM1610415c.88C>Ap.R30RSubstitution - coding silentLiver
COSM5687550c.500G>Ap.R167KSubstitution - MissenseSoft_tissue
COSM3370769c.544G>Cp.D182HSubstitution - MissenseThyroid
COSM1236233c.309G>Tp.K103NSubstitution - MissenseAutonomic_ganglia
COSM4521196c.109G>Ap.E37KSubstitution - MissenseSkin
COSM980586c.135C>Ap.F45LSubstitution - MissenseEndometrium
COSM1302961c.116T>Cp.L39PSubstitution - MissenseUrinary_tract
COSM436777c.358G>Ap.E120KSubstitution - MissenseBreast
COSM3691657c.544G>Tp.D182YSubstitution - MissenseLarge_intestine
COSM357543c.46G>Ap.E16KSubstitution - MissenseStomach
COSM980588c.79C>Ap.L27ISubstitution - MissenseEndometrium
COSM4067325c.328C>Tp.P110SSubstitution - MissenseStomach
COSM4067327c.88C>Tp.R30*Substitution - NonsenseStomach
COSM2697272c.354G>Ap.E118ESubstitution - coding silentLarge_intestine
COSM4827036c.142G>Cp.E48QSubstitution - MissenseCervix
COSM980587c.115C>Tp.L39FSubstitution - MissenseEndometrium
COSM980585c.394_399delCTCATGp.L132_M133delLMDeletion - In frameEndometrium
COSM1383978c.12delAp.K4fs*11Deletion - FrameshiftLarge_intestine
COSM3989098c.403C>Tp.L135LSubstitution - coding silentKidney
COSM301883c.525G>Ap.S175SSubstitution - coding silentCentral_nervous_system
COSM159771c.318+10G>Cp.?UnknownBreast
COSM1383978c.12delAp.K4fs*11Deletion - FrameshiftLarge_intestine
COSM4820051c.465G>Ap.K155KSubstitution - coding silentCervix
COSM1383978c.12delAp.K4fs*11Deletion - FrameshiftLarge_intestine
COSM357543c.46G>Ap.E16KSubstitution - MissenseLung
> Text Mining based Variations
 
There is no record for CBX1.
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Post-translational modification (PTM)
> Post-translational modification (PTM)
 
 Filter By:
Uniprot ID Position Amino Acid Description Upstream Enzyme Affected By Mutation Amino Acid Sequence Variant
P8391691SPhosphoserine-NoNone detected
P83916175SPhosphoserine-NoNone detected
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Expression analysis in primary tumor tissue from TCGA
> Expression level in cancer cell line from CCLE
> Expression level in human normal tissue from HPA
> Text mining based expression change
> The Cancer Genome Atlas (TCGA)
 


  Differential expression analysis for cancers with more than 10 normal samples
Cancer Full Name # N # T Median (N) Median (T) LogFC Adj. P Status
BLCABladder urothelial carcinoma194086.0866.440.4850.000866NS
BRCABreast invasive carcinoma11211006.2096.7710.6111.12e-21Over
CESCCervical and endocervical cancers33066.7096.58NANANA
COADColon adenocarcinoma414595.6225.9620.2720.00232NS
ESCAEsophageal carcinoma111854.8625.5880.7870.00681Over
GBMGlioblastoma multiforme51666.9736.987NANANA
HNSCHead and Neck squamous cell carcinoma445225.5116.1820.6543.57e-13Over
KIRCKidney renal clear cell carcinoma725346.2966.007-0.2925.5e-11NS
KIRPKidney renal papillary cell carcinoma322916.0316.2180.1560.0691NS
LAMLAcute Myeloid Leukemia0173NA5.432NANANA
LGGBrain Lower Grade Glioma0530NA7.24NANANA
LIHCLiver hepatocellular carcinoma503734.1294.790.7834.58e-17Over
LUADLung adenocarcinoma595175.6216.2620.7063.84e-18Over
LUSCLung squamous cell carcinoma515015.6026.7671.2126.13e-33Over
OVOvarian serous cystadenocarcinoma0307NA6.032NANANA
PAADPancreatic adenocarcinoma41795.8175.806NANANA
PCPGPheochromocytoma and Paraganglioma31845.6236.573NANANA
PRADProstate adenocarcinoma524986.0786.1190.0680.22NS
READRectum adenocarcinoma101675.715.9210.1370.579NS
SARCSarcoma22636.126.881NANANA
SKCMSkin Cutaneous Melanoma14726.3746.21NANANA
STADStomach adenocarcinoma354155.2045.5180.2140.0372NS
TGCTTesticular Germ Cell Tumors0156NA7.581NANANA
THCAThyroid carcinoma595096.4916.162-0.3118.9e-13NS
THYMThymoma21206.5426.694NANANA
UCECUterine Corpus Endometrial Carcinoma355466.9876.526-0.2110.1NS
> Cancer Cell Line Encyclopedia (CCLE)
 

There is no record.
> The Human Protein Atlas (HPA)
 


Tissue Expression Level (TPM)
Adipose tissue 34.5
Adrenal gland 40.6
Appendix 48.7
Bone marrow 10.5
Breast 46
Cerebral cortex 105.9
Cervix, uterine 74.2
Colon 32.8
Duodenum 19.4
Endometrium 108.4
Epididymis 57.6
Esophagus 31.5
Fallopian tube 59.3
Gallbladder 43.2
Heart muscle 22
Kidney 40.2
Liver 10.9
Lung 39.7
Lymph node 40.5
Ovary 93.6
Pancreas 3.7
Parathyroid gland 70.4
Placenta 48.4
Prostate 60.4
Rectum 36.8
Salivary gland 11.4
Seminal vesicle 64.3
Skeletal muscle 23.5
Skin 33.7
Small intestine 23
Smooth muscle 79.9
Spleen 46.5
Stomach 19.9
Testis 125.1
Thyroid gland 65
Tonsil 43.9
Urinary bladder 35.2
> Text Mining based Expression
 
PMID Expression Cancer Evidence
28403887overexpressionProstate CarcinomaWe then ran a factorial discriminant analysis (FDA) and compared the enriched genes in prostate-tumor biopsies and normal biopsies using ANOVA to identify significantly differentially-enriched genes. The analysis identified ALG5, EXOSC8, CBX1, GRID2, GRIN3B, ING3, MYO1D, NPHP3-AS1, MSH6, FBXO11, SND1, SPATS2, TENM4 and TRA2A genes.
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Somatic copy number alteration in primary tomur tissue
> The Cancer Genome Atlas (TCGA)
 


  Correlation between expression and SCNA as well as percentage of patients in different status.
Cancer Full Name # Sample R P % Loss % Neutral % Gain Status
BLCABladder urothelial carcinoma4040.5184.35e-297.753.538.9Gain
BRCABreast invasive carcinoma10750.691.08e-1522548.426.6Neutral
CESCCervical and endocervical cancers2920.4393.45e-159.671.618.8Neutral
COADColon adenocarcinoma4490.4363.19e-2212.966.120.9Neutral
ESCAEsophageal carcinoma1830.3643.96e-071255.232.8Neutral
GBMGlioblastoma multiforme1470.4267.55e-089.578.911.6Neutral
HNSCHead and Neck squamous cell carcinoma5140.4175.19e-23775.317.7Neutral
KIRCKidney renal clear cell carcinoma5250.3242.57e-145.587.86.7Neutral
KIRPKidney renal papillary cell carcinoma2880.4142.35e-130.332.367.4Gain
LAMLAcute Myeloid Leukemia1660.020.8024.293.42.4Neutral
LGGBrain Lower Grade Glioma5130.4417.58e-263.392.64.1Neutral
LIHCLiver hepatocellular carcinoma3640.4067.35e-167.463.728.8Neutral
LUADLung adenocarcinoma5120.5727.66e-465.149.645.3Gain
LUSCLung squamous cell carcinoma4980.5863.53e-4715.547.636.9Gain
OVOvarian serous cystadenocarcinoma3000.5831.13e-285825.316.7Loss
PAADPancreatic adenocarcinoma1770.2370.00152975.715.3Neutral
PCPGPheochromocytoma and Paraganglioma1620.6162.83e-1812.382.15.6Neutral
PRADProstate adenocarcinoma4910.3271.08e-134.591.44.1Neutral
READRectum adenocarcinoma1640.3222.69e-0514.662.822.6Neutral
SARCSarcoma2550.4953.74e-1716.956.926.3Neutral
SKCMSkin Cutaneous Melanoma3670.5845.89e-3516.658.924.5Neutral
STADStomach adenocarcinoma4130.4186.59e-1913.664.422Neutral
TGCTTesticular Germ Cell Tumors1500.1990.01486.75637.3Gain
THCAThyroid carcinoma4970.2821.54e-100.295.64.2Neutral
THYMThymoma1190.0590.5263.489.17.6Neutral
UCECUterine Corpus Endometrial Carcinoma5370.3951.83e-2114.774.510.8Neutral
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Methylation level in the promoter region of CR
> Methylation level in the promoter region of CR
 


  Correlation between expression and methylation as well as differential methylation analysis.
Cancer Full Name R P # N # T Delta beta (T vs N) P value (T vs N) Status
BLCABladder urothelial carcinoma-0.1520.0017217408-0.0010.416NS/NA
BRCABreast invasive carcinoma-0.32.05e-1983785-0.0010.348NS/NA
CESCCervical and endocervical cancers-0.1690.002953306NANANS/NA
COADColon adenocarcinoma-0.2921.45e-07192970.0010.28NS/NA
ESCAEsophageal carcinoma-0.3071.52e-059185NANANS/NA
GBMGlioblastoma multiforme-0.3720.00241164NANANS/NA
HNSCHead and Neck squamous cell carcinoma-0.1726.02e-052052200.294NS/NA
KIRCKidney renal clear cell carcinoma-0.2213.92e-05243190.0045.79e-12NS/NA
KIRPKidney renal papillary cell carcinoma-0.1950.000722232750.0020.653NS/NA
LAMLAcute Myeloid Leukemia-0.4018.1e-080170NANANS/NA
LGGBrain Lower Grade Glioma-0.1070.01380530NANANS/NA
LIHCLiver hepatocellular carcinoma-0.1620.000919413730.0030.00206NS/NA
LUADLung adenocarcinoma-0.1350.00321214560.0190.000347NS/NA
LUSCLung squamous cell carcinoma-0.2784.3e-088370NANANS/NA
OVOvarian serous cystadenocarcinoma-0.850.0060709NANANS/NA
PAADPancreatic adenocarcinoma-0.1440.05234179NANANS/NA
PCPGPheochromocytoma and Paraganglioma-0.2829.94e-053184NANANS/NA
PRADProstate adenocarcinoma-0.1350.0018335498-0.0467.74e-09NS/NA
READRectum adenocarcinoma-0.2880.00358299NANANS/NA
SARCSarcoma-0.2399.5e-050263NANANS/NA
SKCMSkin Cutaneous Melanoma-0.4101471NANANS/NA
STADStomach adenocarcinoma-0.1750.0007110372NANANS/NA
TGCTTesticular Germ Cell Tumors-0.2850.0003280156NANANS/NA
THCAThyroid carcinoma-0.0660.121505090.030.0684NS/NA
THYMThymoma-0.2450.006642120NANANS/NA
UCECUterine Corpus Endometrial Carcinoma-0.1865.68e-0534431-0.0010.738NS/NA
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Primary tumor tissue from TCGA
> Normal tumor tissue from HPA
>The Cancer Genome Atlas (TCGA)
 
There is no record.
> The Human Protein Atlas (HPA)
 


Tissue Level Level Name
Adrenal gland 2 Medium
Appendix 2 Medium
Bone marrow 3 High
Breast 2 Medium
Bronchus 3 High
Caudate 3 High
Cerebellum 3 High
Cerebral cortex 3 High
Cervix, uterine 3 High
Colon 3 High
Duodenum 3 High
Endometrium 2 Medium
Epididymis 2 Medium
Esophagus 2 Medium
Fallopian tube 2 Medium
Gallbladder 3 High
Heart muscle 2 Medium
Hippocampus 3 High
Kidney 2 Medium
Liver 2 Medium
Lung 2 Medium
Lymph node 2 Medium
Nasopharynx 3 High
Oral mucosa 2 Medium
Ovary 3 High
Pancreas 3 High
Parathyroid gland 3 High
Placenta 3 High
Prostate 2 Medium
Rectum 3 High
Salivary gland 3 High
Seminal vesicle 3 High
Skeletal muscle 3 High
Skin 3 High
Small intestine 2 Medium
Smooth muscle 3 High
Soft tissue 3 High
Spleen 2 Medium
Stomach 3 High
Testis 3 High
Thyroid gland 3 High
Tonsil 2 Medium
Urinary bladder 3 High
Vagina 2 Medium
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Association between expresson and subtype
> Overall survival analysis based on expression
> Association between expresson and stage
> Association between expresson and grade
> Subtype
 


  Association between expresson and subtype.
Cancer Full Name # Patients P Value (Kruskal-Wallis) Association Source
BLCABladder urothelial carcinoma1280.045Significant24476821
BRCABreast invasive carcinoma5215.19e-09Significant23000897
COADColon adenocarcinoma1490.63NS22810696
GBMGlioblastoma multiforme1572.52e-06Significant26824661
HNSCHead and Neck squamous cell carcinoma2795.51e-08Significant25631445
KIRPKidney renal papillary cell carcinoma1610.197NS26536169
LGGBrain Lower Grade Glioma5132.78e-16Significant26824661
LUADLung adenocarcinoma2301.53e-06Significant25079552
LUSCLung squamous cell carcinoma1786.62e-20Significant22960745
OVOvarian serous cystadenocarcinoma2872.29e-12Significant21720365
PRADProstate adenocarcinoma3337.5e-07Significant26544944
READRectum adenocarcinoma670.713NS22810696
SKCMSkin Cutaneous Melanoma3150.487NS26091043
STADStomach adenocarcinoma2770.562NS25079317
THCAThyroid carcinoma3916.33e-09Significant25417114
UCECUterine Corpus Endometrial Carcinoma2320.0596NS23636398
> Overall survival
 

  Overall survival analysis based on expression.
Cancer Full Name # Patients Hazard Ratio P Value (Log Rank Test) Association
BLCABladder urothelial carcinoma405 1.0750.741NS
BRCABreast invasive carcinoma1079 1.3110.25NS
CESCCervical and endocervical cancers291 1.0080.979NS
COADColon adenocarcinoma439 0.9240.787NS
ESCAEsophageal carcinoma184 1.0530.888NS
GBMGlioblastoma multiforme158 1.0190.943NS
HNSCHead and Neck squamous cell carcinoma518 1.3110.153NS
KIRCKidney renal clear cell carcinoma531 0.9450.785NS
KIRPKidney renal papillary cell carcinoma287 3.8260.00117Shorter
LAMLAcute Myeloid Leukemia149 0.8480.582NS
LGGBrain Lower Grade Glioma511 0.4440.000803Longer
LIHCLiver hepatocellular carcinoma365 2.3730.000587Shorter
LUADLung adenocarcinoma502 1.550.0419Shorter
LUSCLung squamous cell carcinoma494 0.8460.398NS
OVOvarian serous cystadenocarcinoma303 1.1330.559NS
PAADPancreatic adenocarcinoma177 0.8340.551NS
PCPGPheochromocytoma and Paraganglioma179 2.4550.422NS
PRADProstate adenocarcinoma497 1.5940.52NS
READRectum adenocarcinoma159 0.570.336NS
SARCSarcoma259 1.6550.0762NS
SKCMSkin Cutaneous Melanoma459 1.1360.474NS
STADStomach adenocarcinoma388 1.1760.478NS
TGCTTesticular Germ Cell Tumors134 0.9140.949NS
THCAThyroid carcinoma500 0.9550.948NS
THYMThymoma119 00.00377Longer
UCECUterine Corpus Endometrial Carcinoma543 1.780.0352Shorter
> Stage
 

  Association between expresson and stage.
Cancer Full Name # Patients R Value (Spearman) P Value (Spearman) Association
BLCABladder urothelial carcinoma406 0.040.421NS
BRCABreast invasive carcinoma1071 0.0010.967NS
CESCCervical and endocervical cancers167 -0.2040.00813Lower
COADColon adenocarcinoma445 0.0580.221NS
ESCAEsophageal carcinoma162 0.0350.663NS
HNSCHead and Neck squamous cell carcinoma448 0.0880.0623NS
KIRCKidney renal clear cell carcinoma531 -0.0820.0585NS
KIRPKidney renal papillary cell carcinoma260 0.1220.0495Higher
LIHCLiver hepatocellular carcinoma347 0.2242.57e-05Higher
LUADLung adenocarcinoma507 0.0550.214NS
LUSCLung squamous cell carcinoma497 0.070.121NS
OVOvarian serous cystadenocarcinoma302 -0.0690.233NS
PAADPancreatic adenocarcinoma176 -0.1550.0395Lower
READRectum adenocarcinoma156 0.0920.254NS
SKCMSkin Cutaneous Melanoma410 -0.1230.0124Lower
STADStomach adenocarcinoma392 -0.0590.247NS
TGCTTesticular Germ Cell Tumors81 0.2230.0452Higher
THCAThyroid carcinoma499 -0.0180.684NS
UCECUterine Corpus Endometrial Carcinoma501 0.1240.00529Higher
> Grade
 

  Association between expresson and grade.
Cancer Full Name # Patients R Value (Spearman) P Value (Spearman) Association
CESCCervical and endocervical cancers272 0.1790.00305Higher
HNSCHead and Neck squamous cell carcinoma498 0.1370.00226Higher
KIRCKidney renal clear cell carcinoma525 -0.1520.000476Lower
LGGBrain Lower Grade Glioma514 -0.1190.00672Lower
LIHCLiver hepatocellular carcinoma366 0.2241.46e-05Higher
OVOvarian serous cystadenocarcinoma296 -0.0450.436NS
PAADPancreatic adenocarcinoma176 -0.0360.631NS
STADStomach adenocarcinoma406 0.0430.39NS
UCECUterine Corpus Endometrial Carcinoma534 0.3194.35e-14Higher
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Targets inferred by reverse engineering method
> Targets identified by ChIP-seq data
> Targets inferred by reverse engineering method
 
> Targets identified by ChIP-seq data
 
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Drugs from DrugBank database
> Drugs from DrugBank database
 
There is no record for CBX1.
Summary
SymbolCBX1
Namechromobox 1
Aliases HP1Hs-beta; M31; MOD1; CBX; HP1-BETA; HP1 beta homolog (Drosophila ); chromobox homolog 1 (Drosophila HP1 be ......
Location17q21.32
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Cancer Gene Databases ONGene (Oncogene) , TSGene (Tumor suppressor gene) , NCG (Network of Cancer Genes)
Content > Protein-Protein Interaction Network
> miRNA Regulatory Relationship
> Interactions from Text Mining
> Protein-Protein Interaction Network
 
> miRNA Regulatory Relationship
 
> Interactions from Text Mining
 
There is no record for CBX1.